ESMO 2017

Area: Oncology

Location: Madrid, Spain

Date: September 8 to September 12

Description:

European Society for Medical Oncology Conference.


Search in Scientific Content:
Date
Filters:
Second lin...
4:57

Second line therapy – current strategies and clinical management

Presenter: Enrique Grande
Oncology

Therapeutic options for the patient beyond 2nd line in mCRC

Presenter: Alfredo Carrato
Oncology

Optimal management of mCRC: From complexity to clarity

Presenter: Dan Aderka
Oncology

Biosimilars for Oncologists: what you need to know

Presenter: Fernando de Mora Perez
Oncology

Researching the Potential of Checkpoint Inhibitors in HCC (BMS) Expect the unexpected (Roche)

Presenter: Ignacio Melero
Oncology

Putting the patient fiPutting the patient firstrst

Presenter: Geoffrey Henning
Oncology

Treatment Decisions for HR+, HER2– Advanced Breast Cancer

Presenter: Olivia Pagani
Oncology

Clinical Evidence of Biosimilar Trastuzumab

Presenter: Justin Stebbing
Oncology

Biosimilar in Oncology: Yesterday, Today and a Look Ahead: Welcome and Introduction

Presenter: Francisco J. Esteva
Oncology
Clinical E
5:010

Clinical Efficacy of Atezolizumab (Atezo) in PD-L1 Subgroups Defined by SP142 and 22C3 IHC Assays in 2L+ NSCLC: Results From the Randomized OAK Study (ROCHE )/ Treating unresectable malignant pleural mesothelioma: current options and future outlook 2.

Presenter: Shirish Madhav Gadgeel
Oncology

Clinical Efficacy of Atezolizumab (Atezo) in PD-L1 Subgroups Defined by SP142 and 22C3 IHC Assays in 2L+ NSCLC: Results From the Randomized OAK Study (ROCHE )/ Treating unresectable malignant pleural mesothelioma: current options and future outlook

Presenter: Shirish Madhav Gadgeel
Oncology

Can PARP inhibitors offer benefit for all patients with platinum-sensitive ovarian cancer?

Presenter: Sven Mahner
Oncology

ESMO guideline: supportive care, nutrition, cancer anorexia & cachexia syndrome

Presenter: Henk van Halteren
Oncology

A look to the future: How are real-world research initiatives evolving?

Presenter: Frank Griesinger
Oncology

The burden of CAT: acknowledging the risk

Presenter: Anthony Maraveyas
Oncology

Optimal treatment sequencing in mCRC + Discussion

Presenter: Dirk Arnold
Oncology

EADO 2019

2019-04-24 - 2019-04-27
Paris, France

BCC 2019

2019-03-20 - 2018-03-23
Vienna, Austria

SABCS 2018

2018-12-04 - 2018-12-08
San Antonio, United States

ESMO 2018

2018-10-19 - 2018-10-23
Munich, Germany

ASCO 2018

2018-06-01 - 2018-06-05
Chicago, United States

ECCO 2018

2018-02-14 - 2018-02-17
Vienna, Austria

SABCS 2017

2017-12-05 - 2017-12-09
San Antonio, United States

ICML 2017

2017-06-14 - 2017-06-17
Lugano, Switzerland

ASCO 2017

2017-06-02 - 2017-06-06
Chicago, United States